HF
ALLR

HRT Financial’s Allarity Therapeutics ALLR Stock Holding History

HRT Financial’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Buy
+37,003
New +$52.5K ﹤0.01% 3786
2026
Q1 		– Sell
-10,347
Closed -$11K – 3722
2025
Q4 		$11K Buy
+10,347
New +$13.2K ﹤0.01% 3038
2024
Q3 		– Sell
-1,156
Closed -$7K – 2354
2024
Q2 		$7K Buy
+1,156
New +$45.4K ﹤0.01% 2017

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

HRT Financial's ALLR Position: Q2 2026 in Review

HRT Financial opened a new position in Allarity Therapeutics (ALLR) in Q2 2026: 37,003 shares worth $47K. The stake represents ﹤0.01% of the portfolio and ranks #3786 among its holdings. This is a return to the name: HRT Financial previously reported a position in ALLR as recently as Q4 2025.

HRT Financial first reported a position in ALLR in Q2 2024 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • HRT Financial held 37,003 shares of Allarity Therapeutics worth $47K as of Q2 2026.
  • Allarity Therapeutics was a new HRT Financial position in Q2 2026.
  • Allarity Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3786 holding.
  • HRT Financial first reported a position in Allarity Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.